MedPath

To assess the genetic prevalence of NASH related liver cirrhosis in association with matraja bhava (Maternal factor)- A Cross-sectional study

Not Applicable
Conditions
Health Condition 1: K746- Other and unspecified cirrhosis ofliver
Registration Number
CTRI/2023/05/053083
Lead Sponsor
CH BRAHM PRAKASH AYURVEDA CHARAK SANSTHA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Diagnosed patients of NASH Liver cirrhosis

Exclusion Criteria

1. History of Alcohol abuse

2. Pregnant women

3. Participants on medications that causes liver damage.

4. Active or previous infection with hepatitis B and C

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To Assess the genetic prevalence of NASH related liver cirrhosisTimepoint: 8 Weeks
Secondary Outcome Measures
NameTimeMethod
Establishment of association between matraja bhava and Nash related liver cirrhosisTimepoint: 8 Weeks
© Copyright 2025. All Rights Reserved by MedPath